Published in Med J Aust on October 15, 1977
Intersubject and dose-related variability after intravenous administration of erythromycin. Br J Clin Pharmacol (1980) 1.39
Potential for extending survival of peripheral intravenous infusions. BMJ (1992) 0.95
Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. Int J Clin Oncol (2014) 0.81
Survival of intravenous chemotherapy infusion sites. Br J Cancer (1990) 0.80
Prevalence of depression and distress in a large sample of Canadian residents, interns, and fellows. Am J Psychiatry (1987) 3.12
Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis (2000) 2.18
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg (1992) 1.68
Self-expanding metal stents in the management of colorectal carcinoma--a preliminary report. Clin Radiol (1998) 1.56
Antibacterial activity of the lactoperoxidase system in milk against pseudomonads and other gram-negative bacteria. Appl Microbiol (1975) 1.52
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes. J Immunol Methods (1977) 1.42
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41
Vaccination therapy in malignant disease. Surgeon (2006) 1.40
Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg (1999) 1.38
Natural killer cells and cancer. Cancer (1996) 1.33
Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg (1997) 1.30
Simple renal hypothermia. Br J Urol (1974) 1.27
Varicocoele caused by a pancreatic pseudocyst. Gut (1983) 1.21
Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. Exp Parasitol (1994) 1.15
Nutrition and malignant disease: implications for surgical practice. Br J Surg (1992) 1.15
Hidden dangers of sliced bread. Br Med J (Clin Res Ed) (1984) 1.12
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
The effects of smoking on fracture healing. Surgeon (2010) 1.11
Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation (1974) 1.09
Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb (2000) 1.09
Breast cancer in women aged 35 and under: prognosis and survival. J R Coll Surg Edinb (2002) 1.09
Cadaveric renal transplantation. Lancet (1968) 1.07
The residual renal stone. Br J Urol (1975) 1.07
T and B lymphocyte populations in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Int Arch Allergy Appl Immunol (1976) 1.07
Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol (2000) 1.06
Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer (1978) 1.05
Enterolith obstruction of the small bowel. J R Coll Surg Edinb (1985) 1.04
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer (1999) 1.02
Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ (1993) 1.02
Mössbauer studies of cytochrome P-450 cam . Biochemistry (1973) 1.01
Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer (1981) 1.01
Interleukin 2 therapy in cancer: identification of responders. Br J Cancer (1992) 1.00
Cytochrome P450cam and its complexes. Mössbauer parameters of the heme iron. Biochim Biophys Acta (1976) 1.00
Biosynthesis, characterisation, and design of bacterial exopolysaccharides from lactic acid bacteria. Biotechnol Adv (2001) 0.99
Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet (1991) 0.98
Carcinoid tumour of the gall bladder: two case reports and a review of published works. Gut (1993) 0.98
Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr (1994) 0.98
Haemangiopericytoma of the greater omentum. Eur J Surg Oncol (1995) 0.97
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg (1998) 0.97
Characterisation of macrophages infiltrating human mammary carcinomas. Br J Cancer (1985) 0.96
Characterization of the phagocytic cells isolated from the human placenta. J Reticuloendothel Soc (1982) 0.96
Characterization of the human natural killer (NK) cell in blood and lymphoid organs. Int J Cancer (1978) 0.94
Oestrogen receptor concentration and macrophage infiltration in human breast cancer. Eur J Surg Oncol (1986) 0.94
Surface characteristics of the human K (killer) lymphocyte. Int Arch Allergy Appl Immunol (1977) 0.93
Measurement of tumour protein synthesis in vivo in human colorectal and breast cancer and its variability in separate biopsies from the same tumour. Clin Sci (Lond) (1991) 0.93
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon (2003) 0.92
Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol (1994) 0.92
Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation. Int J Cancer (1995) 0.91
Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg (1996) 0.91
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg (1998) 0.91
Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer (1999) 0.91
An examination of loneliness among elderly Canadian seasonal residents in Florida. J Gerontol (1989) 0.91
Minimal modulation of lymphocyte and natural killer cell subsets following minimal access surgery. Am J Surg (1999) 0.90
Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy. Surgeon (2006) 0.90
Epidermal growth factor receptor expression in colorectal cancer. Br J Surg (1990) 0.90
Antibody-dependent cellular cytotoxicity in the rat, rabbit, and guinea pig: relationship of killer (K) cell activity with the presence of Fc+ C3- and Fc+ C3+ lymphocytes. Cell Immunol (1979) 0.90
Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer (1982) 0.90
What is achieved by mammographic surveillance after breast conservation treatment for breast cancer? Am J Surg (2001) 0.90
Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas. Br J Cancer (1990) 0.89
The natural history of renal and ureteric calculi. Br J Urol (1975) 0.89
Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) (1992) 0.89
Killer cell (K) activity in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Int Arch Allergy Appl Immunol (1977) 0.89
Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest (2000) 0.89
Femoral hernia: mortality and morbidity following elective and emergency surgery. J R Coll Surg Edinb (1991) 0.89
Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival. Int J Oncol (1998) 0.88
Renal transplantation--15 years' experience. Br J Surg (1981) 0.88
Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol (1998) 0.87
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon (2003) 0.87
Expandable metal stent application in obstructing carcinoma of the proximal colon: report of a case. Dis Colon Rectum (1997) 0.87
Amino acid incorporation into protein of a surface-active lung fraction. J Appl Physiol (1973) 0.87
T-lymphocyte and B-lymphocyte subpopulations infiltrating human mammary carcinomas. J Natl Cancer Inst (1982) 0.87
Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg (1994) 0.86
Second primary breast cancer. Br Med J (Clin Res Ed) (1988) 0.86
Dendritic cells (I): Biological functions. J R Coll Surg Edinb (2001) 0.86
A high macrophage content in human breast cancer is not associated with favourable prognostic factors. Br J Surg (1984) 0.86
In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model. Br J Cancer (1999) 0.86
Psychological assessment and intervention: future prospects for women with breast cancer. Semin Surg Oncol (1996) 0.86
Antibody-dependent cellular cytotoxicity and natural cytotoxicity: effect of pre-treatment of human lymphocytes with deionised water and ammonium chloride. J Immunol Methods (1978) 0.86
Immune suppression and isolated severe head injury: a significant clinical problem. Br J Neurosurg (2003) 0.86
Is urography necessary for patients with acute retention of urine before prostatectomy? Br J Urol (1975) 0.85
Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Lond) (1994) 0.85
Psychologic distress during the menopausal years in women attending a menopause clinic. Int J Psychiatry Med (1992) 0.85
An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer (1990) 0.85
Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery (1995) 0.85
Haemoperitoneum due to traumatic rupture of a hepatoma in a patient with haemochromatosis. J R Coll Surg Edinb (1982) 0.85
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study. Eur J Cancer Clin Oncol (1989) 0.85
Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease. Eur J Surg Oncol (1995) 0.84
Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol (1995) 0.84
The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology (1997) 0.84
Reversal of Hartmann's colostomy. J R Coll Surg Edinb (1994) 0.83
Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology (1997) 0.83
Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer (2004) 0.83
Surgical sepsis: dysregulation of immune function and therapeutic implications. Surgeon (2003) 0.83
Urinary cytokines as markers of reflux nephropathy. J Urol (1999) 0.82
Principles of proteomics and its applications in cancer. Surgeon (2007) 0.82